Historically, studies to identify cancer causing genetic alterations and interactions have been limited to single genes or proteins. Yet, alterations of biological processes involves coordinated changes in the expression of dozens or more genes. With the availability of the complete sequence of the human and mouse genomes, experimentalists can now use global approaches that simultaneously examine multitudes of genes. In addition, the ability to collect these rich data from clinical specimens is growing rapidly. These developments necessitate the integration of genetics and genomics with clinical medicine. To manage and analyze the complex data sets generated, translational research must be facile with biomedical informatics, bioinformatics and computation biology. In response to these needs, the UNC Breast SPORE has developed Core 1, the Genomics, Genotyping and Bioinformatics shared resource. Under the experienced leadership of the SPORE Co-Pi, Dr. Charles Perou and Dr.Steve Marron, SPORE Core 1 brings together three critical services - high quality DMA microarray services, high-throughput genotyping, andrelated Bioinformatics - andfocuses them ontranslational breast cancer research. Four proposed SPORE projects (1, 3, 4, 5) plan to use the Core. These three Core services are part of two UNC Lineberger Comprehensive Cancer Center shared resources - Genomics & Bioinformatics and the Mammalian High Throughput Genotyping facility. In both these cores, the needs of Breast SPORE investigators and their studies have spurred development of methods and equipment upgrades that benefit and stimulate other Cancer Center research. By supporting key personnel in these two Cancer Center cores, the UNC Breast SPORE is assuring priority service and performance. Dr. Perou's expertise and experience with these services, his leadership in the Cancer Center Genomics & Bioinformatics Core, and Dr. Earp's dual role as Breast SPORE and Cancer Center Director mean that this SPORE Core is integrated into the Cancer Center structure and appropriately providing services to SPORE investigators.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
5P50CA058223-16
Application #
7663920
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2008-08-01
Budget End
2009-07-31
Support Year
16
Fiscal Year
2008
Total Cost
$130,002
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Tanioka, Maki; Mott, Kevin R; Hollern, Daniel P et al. (2018) Identification of Jun loss promotes resistance to histone deacetylase inhibitor entinostat through Myc signaling in luminal breast cancer. Genome Med 10:86
Tanioka, Maki; Fan, Cheng; Parker, Joel S et al. (2018) Integrated Analysis of RNA and DNA from the Phase III Trial CALGB 40601 Identifies Predictors of Response to Trastuzumab-Based Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer. Clin Cancer Res 24:5292-5304
Mundt, Filip; Rajput, Sandeep; Li, Shunqiang et al. (2018) Mass Spectrometry-Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers. Cancer Res 78:2732-2746
Takaku, Motoki; Grimm, Sara A; Roberts, John D et al. (2018) GATA3 zinc finger 2 mutations reprogram the breast cancer transcriptional network. Nat Commun 9:1059
Butler, Eboneé N; Bensen, Jeannette T; Chen, Mengjie et al. (2018) Prediagnostic Smoking Is Associated with Binary and Quantitative Measures of ER Protein and ESR1 mRNA Expression in Breast Tumors. Cancer Epidemiol Biomarkers Prev 27:67-74
Echavarria, Isabel; López-Tarruella, Sara; Picornell, Antoni et al. (2018) Pathological Response in a Triple-Negative Breast Cancer Cohort Treated with Neoadjuvant Carboplatin and Docetaxel According to Lehmann's Refined Classification. Clin Cancer Res 24:1845-1852
Cai, Ling; Tsai, Yi-Hsuan; Wang, Ping et al. (2018) ZFX Mediates Non-canonical Oncogenic Functions of the Androgen Receptor Splice Variant 7 in Castrate-Resistant Prostate Cancer. Mol Cell 72:341-354.e6
Bensen, Jeannette T; Graff, Mariaelisa; Young, Kristin L et al. (2018) A survey of microRNA single nucleotide polymorphisms identifies novel breast cancer susceptibility loci in a case-control, population-based study of African-American women. Breast Cancer Res 20:45
Puvanesarajah, Samantha; Nyante, Sarah J; Kuzmiak, Cherie M et al. (2018) PAM50 and Risk of Recurrence Scores for Interval Breast Cancers. Cancer Prev Res (Phila) 11:327-336
Knott, Simon R V; Wagenblast, Elvin; Khan, Showkhin et al. (2018) Asparagine bioavailability governs metastasis in a model of breast cancer. Nature 554:378-381

Showing the most recent 10 out of 598 publications